Aptus Pharma Promoter Boosts Stake to 5.31% in Off-Market Deal

CHEMICALS
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Aptus Pharma Promoter Boosts Stake to 5.31% in Off-Market Deal
Overview

Aptus Pharma Ltd promoter Ghanshyam Vinubhai Pansuriya has acquired an additional 14,000 shares (0.20%) through an off-market transfer within the promoter group. His total holding now stands at 5.31%, up from 5.10%, signaling continued confidence.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Ghanshyam Vinubhai Pansuriya, a promoter of Aptus Pharma Limited, has increased his stake in the company to 5.31%. He acquired 14,000 equity shares, representing 0.20% of the total share capital, through an off-market share transfer within the promoter group on 11.05.2026. This transaction raised his aggregate shareholding from 5.10% to the current 5.31%.

Aptus Pharma Limited, incorporated in 1994, manufactures Active Pharmaceutical Ingredients (APIs) and pharmaceutical formulations. The company is listed on the NSE Emerge platform.

While this stake increase is modest, a rise in promoter holding can signal management's conviction in the company's future prospects. It is often interpreted as a sign of continued belief in the company's intrinsic value.

Moving forward, investors will likely monitor future quarterly financial results and business updates from Aptus Pharma. Further changes in promoter or institutional investor shareholding, along with company announcements regarding product development or expansion plans, will also be key points of interest.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.